Collectively, this study demonstrates that PFKFB3 small molecule inhibitors loaded in cell membrane nanovesicles can effectively improve glucose metabolism disorder and inflammatory response in an AP rat model. This evidence concerns the gene PFKFB3 and alkaline phosphatase measurement.